(HAL) Halliburton - Ratings and Ratios
Completion, Drilling, Cementing, Wireline, Chemicals, Digital
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.21% |
| Yield on Cost 5y | 3.70% |
| Yield CAGR 5y | 39.41% |
| Payout Consistency | 90.9% |
| Payout Ratio | 28.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 41.6% |
| Value at Risk 5%th | 64.5% |
| Relative Tail Risk | -5.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.44 |
| Alpha | -8.80 |
| CAGR/Max DD | -0.13 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.457 |
| Beta | 1.229 |
| Beta Downside | 1.875 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.01% |
| Mean DD | 26.27% |
| Median DD | 26.42% |
Description: HAL Halliburton December 19, 2025
Halliburton Company (NYSE: HAL) delivers a full suite of oilfield products and services worldwide, organized into two segments: Completion & Production, which handles well stimulation, cementing, intelligent completions, artificial-lift systems, and specialty chemicals; and Drilling & Evaluation, which provides drilling fluids, bit technology, wireline logging, digital AI platforms, and project-management services.
Recent performance highlights include Q4 2024 adjusted EBITDA of roughly $2.1 billion (≈12% YoY growth), a backlog of about $13 billion, and a breakeven oil price near $45 per barrel Brent-metrics that underscore the firm’s sensitivity to commodity cycles.
Key sector drivers remain robust upstream capital spending in North America’s shale plays, OPEC+ production discipline that sustains higher oil prices, and accelerating adoption of cloud-based analytics for subsurface optimization, all of which can amplify demand for Halliburton’s integrated service offerings.
For a deeper, data-driven view of HAL’s valuation outlook, you may find the tools on ValueRay worth a look.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (1.31b TTM) > 0 and > 6% of Revenue (6% = 1.33b TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -2.04pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 25.68% (prev 28.53%; Δ -2.85pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 3.22b > Net Income 1.31b (YES >=105%, WARN >=100%) |
| Net Debt (6.54b) to EBITDA (3.47b) ratio: 1.89 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.95 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (850.0m) change vs 12m ago -3.52% (target <= -2.0% for YES) |
| Gross Margin 16.20% (prev 19.10%; Δ -2.91pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 87.68% (prev 91.09%; Δ -3.41pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.61 (EBITDA TTM 3.47b / Interest Expense TTM 418.0m) >= 6 (WARN >= 3) |
Altman Z'' 5.19
| (A) 0.23 = (Total Current Assets 11.64b - Total Current Liabilities 5.95b) / Total Assets 25.16b |
| (B) 0.58 = Retained Earnings (Balance) 14.59b / Total Assets 25.16b |
| (C) 0.09 = EBIT TTM 2.35b / Avg Total Assets 25.25b |
| (D) 1.13 = Book Value of Equity 16.89b / Total Liabilities 14.92b |
| Total Rating: 5.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 53.20
| 1. Piotroski 4.50pt |
| 2. FCF Yield 5.90% |
| 3. FCF Margin 8.47% |
| 4. Debt/Equity 0.84 |
| 5. Debt/Ebitda 1.89 |
| 6. ROIC - WACC (= -6.70)% |
| 7. RoE 12.59% |
| 8. Rev. Trend 61.81% |
| 9. EPS Trend -21.22% |
What is the price of HAL shares?
Over the past week, the price has changed by +8.21%, over one month by +9.79%, over three months by +27.36% and over the past year by +14.77%.
Is HAL a buy, sell or hold?
- Strong Buy: 12
- Buy: 8
- Hold: 9
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HAL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.2 | 1.2% |
| Analysts Target Price | 31.2 | 1.2% |
| ValueRay Target Price | 31.7 | 2.8% |
HAL Fundamental Data Overview January 06, 2026
P/E Trailing = 19.6027
P/E Forward = 12.8866
P/S = 1.14
P/B = 2.4416
P/EG = 1.4633
Beta = 0.819
Revenue TTM = 22.14b USD
EBIT TTM = 2.35b USD
EBITDA TTM = 3.47b USD
Long Term Debt = 7.16b USD (from longTermDebt, last quarter)
Short Term Debt = 676.0m USD (from shortTermDebt, last quarter)
Debt = 8.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.54b USD (from netDebt column, last quarter)
Enterprise Value = 31.78b USD (25.24b + Debt 8.57b - CCE 2.03b)
Interest Coverage Ratio = 5.61 (Ebit TTM 2.35b / Interest Expense TTM 418.0m)
FCF Yield = 5.90% (FCF TTM 1.87b / Enterprise Value 31.78b)
FCF Margin = 8.47% (FCF TTM 1.87b / Revenue TTM 22.14b)
Net Margin = 5.91% (Net Income TTM 1.31b / Revenue TTM 22.14b)
Gross Margin = 16.20% ((Revenue TTM 22.14b - Cost of Revenue TTM 18.55b) / Revenue TTM)
Gross Margin QoQ = 15.39% (prev 14.86%)
Tobins Q-Ratio = 1.26 (Enterprise Value 31.78b / Total Assets 25.16b)
Interest Expense / Debt = 1.03% (Interest Expense 88.0m / Debt 8.57b)
Taxrate = 90.87% (199.0m / 219.0m)
NOPAT = 214.3m (EBIT 2.35b * (1 - 90.87%))
Current Ratio = 1.95 (Total Current Assets 11.64b / Total Current Liabilities 5.95b)
Debt / Equity = 0.84 (Debt 8.57b / totalStockholderEquity, last quarter 10.20b)
Debt / EBITDA = 1.89 (Net Debt 6.54b / EBITDA 3.47b)
Debt / FCF = 3.49 (Net Debt 6.54b / FCF TTM 1.87b)
Total Stockholder Equity = 10.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.20% (Net Income 1.31b / Total Assets 25.16b)
RoE = 12.59% (Net Income TTM 1.31b / Total Stockholder Equity 10.40b)
RoCE = 13.37% (EBIT 2.35b / Capital Employed (Equity 10.40b + L.T.Debt 7.16b))
RoIC = 1.19% (NOPAT 214.3m / Invested Capital 17.94b)
WACC = 7.89% (E(25.24b)/V(33.80b) * Re(10.54%) + D(8.57b)/V(33.80b) * Rd(1.03%) * (1-Tc(0.91)))
Discount Rate = 10.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.66%
[DCF Debug] Terminal Value 73.76% ; FCFE base≈2.09b ; Y1≈2.57b ; Y5≈4.39b
Fair Price DCF = 58.54 (DCF Value 49.27b / Shares Outstanding 841.6m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -21.22 | EPS CAGR: -37.79% | SUE: -4.0 | # QB: 0
Revenue Correlation: 61.81 | Revenue CAGR: 7.45% | SUE: 1.93 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.50 | Chg30d=+0.006 | Revisions Net=+1 | Analysts=15
EPS next Year (2026-12-31): EPS=2.20 | Chg30d=+0.002 | Revisions Net=+1 | Growth EPS=-2.1% | Growth Revenue=-1.6%
Additional Sources for HAL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle